INTRODUCTION

Exercise is recommended for the prevention of type 2 diabetes mellitus (T2DM) and is known to be effective in correcting metabolic defects, including insulin resistance and lipid disorders. T2DM is induced by obesity in many cases, and weight loss from exercise is beneficial during the clinical treatment of this condition [123].

The exercise intensity that causes the highest rate of fat oxidation is referred to as the 'maximal fat oxidation rate' (Fat_max) intensity [1]. It is possible to reproduce measurements of Fat_max using graded exercise calorimetry [4]. This approach can be used to predict the quantity of lipid that will be metabolized during exercise. The technique uses a specific protocol to determine the appropriate exercise level that causes maximum fat oxidation. It has been suggested that the fat oxidation rate during the Fat_max intensity is approximately 2-fold greater than at any other intensity [5]. Thus, exercise at the Fat_max intensity can be useful to control weight in cases of metabolic syndrome. The clinical relevance of Fat_max is also important when considering an exercise prescription for weight loss by efficiently increasing fat oxidation and insulin sensitivity [1]. Thus, the Fat_max intensity is recommended to maximize the beneficial effects of exercise and weight management in type 2 diabetic [1] and obese [23] populations.

Patients with metabolic syndromes, including insulin resistance, hypertension, reduced high density lipoprotein cholesterol (HDL-C) [6], T2DM [7], and obesity [8], exhibit an impaired ability to oxidize lipids relative to control subjects of equivalent body mass index (BMI) [19]. Previous studies demonstrated that Fat_max intensity occurs at approximately 33% to 65% maximal oxygen uptake (VO₂ max) in control subjects [1011], but is reduced to 33.4% to 46.1% VO₂ max in T2DM patients [10] and to 38% to 53% VO₂ max in obese patients [12]. It should be noted that the Fat_max intensity was determined by different means across different conditions. The rate of fat oxidation over a wide range of exercise intensities has most frequently been measured in Western populations [681113]. Asian populations have distinct obesity profiles [14]. Thus, data collected in different study populations may not be directly comparable. Most cases of T2DM are associated with being overweight or obese, and it has been shown that exercise-induced reductions in weight and fat mass can affect blood glucose control in patients with T2DM. Therefore, assessments of individual fat oxidation rates can be used to determine the optimal exercise intensity for weight loss and improved glucose control in patients with T2DM.

The purpose of this study was to investigate the Fat_max intensity in T2DM patients during graded exercise. Additionally, we compared values with age-, sex-, and BMI-matched controls to establish the optimal exercise intensity that caused Fat_max in Korean women with T2DM.

METHODS

Subjects

This study examined 24 women (T2DM group, 12; control group, 12) matched for age and BMI. The participants were selected from a hospital. Diabetes was defined based on data obtained from an oral glucose tolerance test, and the disease was diagnosed using standard criteria [15]. The duration of diabetes was 7.82±2.13 years. There were no subjects with a history of chronic artery disease, cerebrovascular disease or endocrine disorder except T2DM. The patients were not treated with any hormonal substitutions. The Institutional Review Board at the Kangbuk Samsung Hospital in Korea approved the study protocol according to the Declaration of Helsinki. All subjects were examined after obtaining informed consent for the experimental procedures. The exercise protocol and possible risks and benefits were explained to all patients.

Exercise testing and fat oxidation calculations

The subjects performed a graded exercise test to exhaustion on a cycle ergometer (Monark 894E; Monark Exercise AB, Vansbro, Sweden). A breath device (VmaxST; SensorMedics Inc., Yorba Linda, CA, USA) was used to measure gas exchange. Oxygen uptake (VO₂) and carbon dioxide production (VCO₂) were measured continuously during both the rest and exercise periods. The heart rate (HR) was measured continuously using a Polar Vantage HR monitor (Polar Electro Oy, Kempele, Finland) by telemetry. The test is performed on a cycle ergometer connected to an analyzer. Electrocardiographic monitoring and measurements of VO₂, VCO₂, and the respiratory exchange ratio were performed during the test. The modified protocol was used by Brandou et al. [16]. The workload for each step was calculated from the theoretical maximal power (Wmax), which represents power corresponding to the theoretical VO₂ max [17]. The protocol consisted of a 3-minute warm up at 20% of theoretical Wmax. The warm-up was followed by four 3-minute steady-state workloads at 30%, 40%, 50%, and 60% of Wmax [161819]. The test concluded with a 5-minute passive recovery period. The maximum fat oxidation rate occurs at the point of maximum lipid oxidation induced by the workload. The rate then decreases as carbohydrates (CHO) become the predominant fuel. The Fat_max defines the exercise intensity that elicits Fat_max intensity. The equation for fat oxidation used by Frayn [20] is the following: fat oxidation=1.6946 VO₂-1.7012 VCO₂.

Blood samples

Blood samples were collected in ethylenediaminetetraacetic acid tubes on ice and were immediately centrifuged at 4℃ for 10 minutes. The plasma was stored at -80℃ until analysis. The serum triglyceride, total cholesterol, and HDL-C levels were measured enzymatically using a chemistry analyzer (Hitachi 747; Hitachi, Tokyo, Japan). The low density lipoprotein cholesterol concentrations were estimated using the Friedewald formula [21]. The plasma glucose levels were analyzed using a conventional commercially available assay on an automatic analyzer (Hitachi 612, Automatic Analyzer; Roche, Basel, Switzerland). The serum insulin level was assessed by radioimmunoassay (Bi-Insulin IRMA kit; Schering CIS bio, Gif-surYvette, France). Insulin resistance was estimated using the homeostasis model assessment estimate of insulin resistance index, which was defined as fasting insulin (µU/mL)×fasting plasma glucose (mmol/L)/22.5 [22]. Mitochondrial DNA (mtDNA) in peripheral leukocytes was extracted from 1 mL of whole blood using the QIAamp Tissue Kit 250 (Qiagen Inc., Valencia, CA, USA). The relative mtDNA was measured by a real-time polymerase chain reaction (RT-PCR). The reactions were performed using a Light Cycler-Fast Start DNA Master SYBR Green I kit from Roche Applied Science (Pleasanton, CA, USA). The forward and reverse primers of the mitochondrial gene were the following: 5'-CCACGGGAAACAGCAGTGATT-3' and 5'-CTATTGACTTGGGTTAATCGTGT GA-3', respectively. After denaturation at 50℃ for 2 minutes, the DNA samples were treated at 95℃ for 10 minutes, 90℃ for 15 seconds, and then 40 cycles at 60℃ for 1 minute. The number of PCR cycles required to reach 20 ng of DNA was defined as the threshold cycle.

Data analysis

The statistical analyses were conducted using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA). All data are presented as the means±standard deviation. Student t-test was used to compare subject demographic and laboratory characteristics. Separate 2×2 (intensity and time) mixed measures analysis of variance, repeated for mode, were used to examine the data for fat oxidation. A Spearman correlation analysis was performed to evaluate the relationship among various parameters. P<0.05 was considered statistically significant.

RESULTS

Our results found that the mtDNA, VO₂ max, and Wmax levels in the T2DM group were significantly lower than the control group (P<0.05). The insulin level was also lower in the T2DM group, but the difference was not significant. The glucose level was found to be significantly higher in the T2DM group (P<0.001) (Table 1). The Fat_max intensity was 34.19% of VO₂ max in the T2DM group and 51.80% of VO₂ max in the control group (95% confidence interval, 44.74 to 52.13; P<0.05). The Fat_max intensity of the T2DM group was significantly lower than the control group (t=-2.140, P<0.05) (Fig. 1A). The fat oxidation rate was 0.382 g/min in the T2DM group and 0.545 g/min in the control group. The fat oxidation rate at the Fat_max intensity in the T2DM group was significantly lower than the control group (t=-2.449, P<0.05) (Fig. 1B).

During graded exercise, the fat oxidation rate of the T2DM group was significantly lower, at 40% (P<0.05), 50% (P<0.05), and 60% VO₂ max (P<0.05), than in the control group (Fig. 2).

Fig. 3 shows the linear relationships between the fat oxidation rate, VO₂ max, and insulin level. There was a positive correlation between fat oxidation and the VO₂ max (r=0.770, P<0.001) and insulin (r=0.532, P<0.05) levels. There were no significant differences found in other demographic and laboratory data.

DISCUSSION

This study demonstrates that T2DM patients have significantly reduced fat oxidation compared to control subjects matched in age, sex, weight, height, body fat percentage, and waist circumference. Several studies have reported that fat oxidation decreases in patients with metabolic diseases [1923] and that fat oxidation decreases more with exercise intensity in T2DM patients than in the control groups. Previous studies have also suggested that the range of Fat_max occurs from the 33% to 65% VO₂ max exercise intensity recommended for Fat_max [124]. A review and meta-analyses on the use of calorimetry during exercise reported that the exercise intensity corresponding to Fat_max is approximately 55% to 75% of VO₂ max intensity in the healthy group [1325]. However, maximum fat oxidation occurs at 25% to 50% of VO₂ max intensity in the metabolic disorder group [2627]. Our data showed that Fat_max (34.19% VO₂ max) in T2DM was lower than (51.8% VO₂ max) in the control group. This result also showed that fat oxidation in patients with T2DM was lower, at 40%, 50%, and 60% VO₂ max intensity (P<0.05, each), during incremental exercise compared to controls. Previous studies have reported that Fat_max was at 51.9% VO₂ max [28] in the healthy group and 37% VO₂ max [29] in T2DM patients. The findings were similar to the results of this study. However, another study reported that Fat_max was 25.3% VO₂ max [30] in T2DM and reflects a lower intensity than our T2DM subjects. Differences in Fat_max may be linked to the level of obesity. The BMI of T2DM subjects in previous studies [2829] were similar to our study cases, but the obesity status of T2DM [29] was higher than in our study.

The VO₂ max levels in the T2DM group were 15% lower than those in the control group (P<0.05), and the mtDNA levels in the T2DM group were 42% lower than those in the control group (P<0.05). One reason for low fat oxidation during exercise in T2DM patients was the decrease in mitochondrial fatty acid oxidation [29]. The mitochondrial function in patients with T2DM appears to be disturbed, which may decrease the electron transport chain activity [3031] and subsequently disrupt muscle fatty acid uptake [32]. Increases in oxidative stress can increase hyperinsulinemia and mitochondrial DNA damage to cause T2DM [33]. In this study, the lower mtDNA levels in T2DM patients may be due to the lower VO₂ max and fat oxidation. Recent studies have shown a similar mechanism. Martin et al. [34] reported that T2DM subjects increased CHO oxidation and lower fat oxidation during exercise. Furthermore, regular exercise increased insulin sensitivity and enhanced mitochondrial fatty acid oxidation [35]. An increased capacity to oxidize fat during exercise in patients with T2DM can reduce their dependence on glucose as a source of energy [36] and can serve as an effective means of weight control [37]. In addition, increased fat oxidation through physical activity improves insulin sensitivity [38]. Although subjects without metabolic disorder receive health benefits with moderate-intensity exercise, low-intensity exercise targeted at the level of Fat_max has been shown to markedly improve impaired glucose tolerance and overweight status [39]. Exercise at the Fat_max intensity affects insulin resistance and fat oxidation and can assist in weight management. Therefore, patients with T2DM need the appropriate exercise intensity to help decrease insulin resistance, fasting glucose levels, and improve weight control.

This study showed a positive correlation between VO₂ max and the rate of fat oxidation in T2DM. An individual at a low fitness level can improve their physical activity with low-, moderate- or high-intensity exercise [2537]. Based on the association between VO₂ max and the rate of fat oxidation, we suggest that an elevated fitness level in patients with pathological conditions, such as diabetes, could manage their weight by increasing fat oxidation during exercise and improving clinical status. Thus, it would be useful to extend this approach to people with T2DM. Previous studies on the obese and patients with metabolic syndrome have markedly improved physiological and fitness levels after training at Fat_max intensity [2730]. In this study, the Fat_max intensity of T2DM was significantly lower than in the healthy group. Although Fat_max intensity was seen as a low-intensity exercise, this intensity in T2DM patients improved fat oxidation during exercise and reduced obesity. This study suggests that Fat_max intensity exercise in T2DM patients with a low fitness level involves lower-intensity exercise and can increase fitness levels and improve obesity. In addition, the insulin levels are positively correlated with fat oxidation because of the higher fitness level in the control group. Therefore, patients with T2DM at a low fitness level need an exercise program that emphasizes the attaining VO₂ max.

Our data showed that patients with T2DM have a Fat_max rate of 34.19% VO₂ max, and this intensity is significantly lower than the control group. The Fat_max intensity is positively correlated with VO₂ max. Generally, moderate exercise intensity is recommended for these purposes. However, a previous study reported that low exercise intensity may be helpful, especially for women with T2DM and a low fitness level. Therefore, this study suggests that a lower exercise intensity indicated by Fat_max is recommended for improving fat oxidation and enhancing the fitness level in Korean women with T2DM. These results could be useful when considering an exercise regimen to improve patient health and fitness.

NOTES

CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.

REFERENCES

• 1. Ghanassia E, Brun JF, Fedou C, Raynaud E, Mercier J. Substrate oxidation during exercise: type 2 diabetes is associated with a decrease in lipid oxidation and an earlier shift towards carbohydrate utilization. Diabetes Metab 2006;32:604-610. ArticlePubMed
• 2. Perez-Martin A, Dumortier M, Raynaud E, Brun JF, Fedou C, Bringer J, Mercier J. Balance of substrate oxidation during submaximal exercise in lean and obese people. Diabetes Metab 2001;27(4 Pt 1):466-474. PubMed
• 3. Sardinoux M, Brun JF, Lefebvre P, Bringer J, Fabre G, Salsano V, Fabre JM, Nocca D. Influence of bariatric surgery on exercice maximal lipid oxydation point in grade 3 obese patients. Fundam Clin Pharmacol 2009;23(Suppl 1):57.
• 4. Brun JF, Malatesta D, Sartorio A. Maximal lipid oxidation during exercise: a target for individualizing endurance training in obesity and diabetes? J Endocrinol Invest 2012;35:686-691. PubMed
• 5. Sahlin K, Sallstedt EK, Bishop D, Tonkonogi M. Turning down lipid oxidation during heavy exercise: what is the mechanism? J Physiol Pharmacol 2008;59(Suppl 7):19-30.
• 6. Friedlander AL, Casazza GA, Horning MA, Buddinger TF, Brooks GA. Effects of exercise intensity and training on lipid metabolism in young women. Am J Physiol 1998;275(5 Pt 1):E853-E863. ArticlePubMed
• 7. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 1999;277(6 Pt 1):E1130-E1141. ArticlePubMed
• 8. Van Aggel-Leijssen DP, Saris WH, Hul GB, Van Baak MA. Long-term effects of low-intensity exercise training on fat metabolism in weight-reduced obese men. Metabolism 2002;51:1003-1010. ArticlePubMed
• 9. Mogensen M, Vind BF, Hojlund K, Beck-Nielsen H, Sahlin K. Maximal lipid oxidation in patients with type 2 diabetes is normal and shows an adequate increase in response to aerobic training. Diabetes Obes Metab 2009;11:874-883. ArticlePubMed
• 10. Metz L, Sirvent P, Py G, Brun JF, Fedou C, Raynaud E, Mercier J. Relationship between blood lactate concentration and substrate utilization during exercise in type 2 diabetic postmenopausal women. Metabolism 2005;54:1102-1107. ArticlePubMed
• 11. Cheneviere X, Borrani F, Droz D, Gojanovic B, Malatesta D. Effects of 2 different prior endurance exercises on whole-body fat oxidation kinetics: light vs. heavy exercise. Appl Physiol Nutr Metab 2012;37:955-964. ArticlePubMed
• 12. Larsen S, Ara I, Rabol R, Andersen JL, Boushel R, Dela F, Helge JW. Are substrate use during exercise and mitochondrial respiratory capacity decreased in arm and leg muscle in type 2 diabetes? Diabetologia 2009;52:1400-1408. ArticlePubMedPDF
• 13. Achten J, Gleeson M, Jeukendrup AE. Determination of the exercise intensity that elicits maximal fat oxidation. Med Sci Sports Exerc 2002;34:92-97. ArticlePubMed
• 14. Takagi S, Sakamoto S, Midorikawa T, Konishi M, Katsumura T. Determination of the exercise intensity that elicits maximal fat oxidation in short-time testing. J Sports Sci 2014;32:175-182. ArticlePubMed
• 15. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications report of a WHO consultation: part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
• 16. Brandou F, Dumortier M, Garandeau P, Mercier J, Brun JF. Effects of a two-month rehabilitation program on substrate utilization during exercise in obese adolescents. Diabetes Metab 2003;29:20-27. ArticlePubMed
• 17. Wasserman K, Beaver WL, Whipp BJ. Mechanisms and patterns of blood lactate increase during exercise in man. Med Sci Sports Exerc 1986;18:344-352. ArticlePubMed
• 18. Simoneau JA, Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol (1985) 1997;83:166-171. ArticlePubMed
• 19. Brun JF, Jean E, Ghanassia E, Flavier S, Mercier J. Metabolic training: new paradigms of exercise training for metabolic diseases with exercise calorimetry targeting individuals. Ann Readapt Med Phys 2007;50:528-534. ArticlePubMed
• 20. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol 1983;55:628-634. ArticlePubMed
• 21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502. ArticlePubMedPDF
• 22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. ArticlePubMedPDF
• 23. Toledo FG, Menshikova EV, Ritov VB, Azuma K, Radikova Z, DeLany J, Kelley DE. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes 2007;56:2142-2147. ArticlePubMedPDF
• 24. Dumortier M, Brandou F, Perez-Martin A, Fedou C, Mercier J, Brun JF. Low intensity endurance exercise targeted for lipid oxidation improves body composition and insulin sensitivity in patients with the metabolic syndrome. Diabetes Metab 2003;29:509-518. ArticlePubMed
• 25. Mendelson M, Jinwala K, Wuyam B, Levy P, Flore P. Can crossover and maximal fat oxidation rate points be used equally for ergocycling and walking/running on a track? Diabetes Metab 2012;38:264-270. ArticlePubMed
• 26. Snowling NJ, Hopkins WG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care 2006;29:2518-2527. ArticlePubMedPDF
• 27. Lazzer S, Busti C, Agosti F, De Col A, Pozzo R, Sartorio A. Optimizing fat oxidation through exercise in severely obese Caucasian adolescents. Clin Endocrinol (Oxf) 2007;67:582-588. ArticlePubMed
• 28. Riddell MC, Jamnik VK, Iscoe KE, Timmons BW, Gledhill N. Fat oxidation rate and the exercise intensity that elicits maximal fat oxidation decreases with pubertal status in young male subjects. J Appl Physiol (1985) 2008;105:742-748. ArticlePubMed
• 29. Bordenave S, Metz L, Flavier S, Lambert K, Ghanassia E, Dupuy AM, Michel F, Puech-Cathala AM, Raynaud E, Brun JF, Mercier J. Training-induced improvement in lipid oxidation in type 2 diabetes mellitus is related to alterations in muscle mitochondrial activity. Effect of endurance training in type 2 diabetes. Diabetes Metab 2008;34:162-168. ArticlePubMed
• 30. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51:2944-2950. ArticlePubMedPDF
• 31. Mogensen M, Sahlin K, Fernstrom M, Glintborg D, Vind BF, Beck-Nielsen H, Hojlund K. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007;56:1592-1599. ArticlePubMedPDF
• 32. Kelley DE, Simoneau JA. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 1994;94:2349-2356. ArticlePubMedPMC
• 33. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007;50:790-796. ArticlePubMedPMCPDF
• 34. Martin IK, Katz A, Wahren J. Splanchnic and muscle metabolism during exercise in NIDDM patients. Am J Physiol 1995;269(3 Pt 1):E583-E590. ArticlePubMed
• 35. Bruce CR, Thrush AB, Mertz VA, Bezaire V, Chabowski A, Heigenhauser GJ, Dyck DJ. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab 2006;291:E99-E107. ArticlePubMed
• 36. Hordern MD, Marwick TH, Wood P, Cooney LM, Prins JB, Coombes JS. Acute response of blood glucose to short-term exercise training in patients with type 2 diabetes. J Sci Med Sport 2011;14:238-242. ArticlePubMed
• 37. Mohebbi H, Azizi M. Maximal fat oxidation at the different exercise intensity in obese and normal weight man in the morning and evening. J Hum Sport Exerc 2011;6:49-58.
• 38. Manetta J, Brun JF, Perez-Martin A, Callis A, Prefaut C, Mercier J. Fuel oxidation during exercise in middle-aged men: role of training and glucose disposal. Med Sci Sports Exerc 2002;34:423-429. ArticlePubMed
• 39. Zakrzewski JK, Tolfrey K. Acute effect of Fatmax exercise on the metabolism in overweight and nonoverweight girls. Med Sci Sports Exerc 2012;44:1698-1705. ArticlePubMed

Fig. 1

Comparison of the maximal fat oxidation (Fat_max) intensity (A) and fat oxidation rate at the Fat_max intensity (B) between the type 2 diabetes mellitus (T2DM) and the control groups. ^aP<0.05.

Fig. 2

Comparison of fat oxidation in the type 2 diabetes mellitus (T2DM) and the control groups. VO₂ max, maximal oxygen uptake. ^aP<0.05.

Fig. 3

Linear correlation of fat oxidation with (A) maximal oxygen uptake (VO₂ max) and (B) insulin.

Table 1

Comparisons of the demographic and laboratory data of the type 2 diabetes mellitus and the control groups

Variable	Diabetes (n=12)	Control (n=12)	P value
Age, yr	57.73±7.35	55.01±6.84	0.367
Height, cm	152.65±4.11	155.78±4.99	0.118
Weight, kg	60.66±9.36	63.25±13.13	0.594
%body fat, %	34.40±5.59	36.07±5.38	0.792
BMI, kg/m2	26.05±4.07	25.95±4.49	0.957
Waist, cm	90.51±8.53	84.67±11.36	0.219
TC, mg/dL	199.90±27.17	202.00±42.10	0.896
HDL-C, mg/dL	48.50±9.98	49.90±9.43	0.751
LDL-C, mg/dL	126.90±30.57	125.90±40.15	0.951
TG, mg/dL	157.00±66.68	177.80±53.91	0.453
Glucose, mg/dL	133.20±20.07	73.50±20.10	<0.001
Insulin, µg/mL	5.24±1.78	9.50±6.04	0.075
HOMA-IR	34.11±15.14	28.68±23.96	0.585
mtDNA, mtDNA/β-actin	11.38±4.17	16.20±6.17	0.038
VO2 max, mL/kg/min	23.44±2.88	27.62±3.38	0.039
Wmax, W	135.95±16.91	156.86±22.91	0.047

BMI, body mass index; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TG, triglyceride; HOMA-IR, homeostasis model assessment estimate of insulin resistance; mtDNA, mitochondrial DNA; VO₂ max, maximal oxygen uptake; Wmax, maximal power.

Figure & Data

References

Citations

Citations to this article as recorded by  

• Toward Exercise Guidelines for Optimizing Fat Oxidation During Exercise in Obesity: A Systematic Review and Meta-Regression
  Isaac A. Chávez-Guevara, Francisco J. Amaro-Gahete, Arnulfo Ramos-Jiménez, Jean Frederic Brun
  Sports Medicine.2023; 53(12): 2399.     CrossRef
• Cardiorespiratory fitness in individuals with type 2 diabetes mellitus: a systematic review and meta-analysis
  Aline Chagastelles Pinto de Macedo, Camila Wohlgemuth Schaan, Patricia Martins Bock, Mariana Brutto de Pinto, Cintia Ehlers Botton, Daniel Umpierre, Beatriz D. Schaan
  Archives of Endocrinology and Metabolism.2023;[Epub]     CrossRef
• Inclusion of sprints during moderate-intensity continuous exercise enhances post-exercise fat oxidation in young males
  Bruno Nicanor Mello-Silva, Gabriel Völz Protzen, Fabrício Boscolo Del Vecchio
  Applied Physiology, Nutrition, and Metabolism.2022; 47(2): 165.     CrossRef
• Resting and exercise metabolic characteristics in obese children with insulin resistance
  Cao Youxiang, Zhu Lin, Chen Zekai, Xie Weijun
  Frontiers in Physiology.2022;[Epub]     CrossRef
• Impact of Acute Eccentric versus Concentric Running on Exercise-Induced Fat Oxidation and Postexercise Physical Activity in Untrained Men
  Shaea Alkahtani, Osama Aljuhani, Nasser Alkhalidi, Naif Almasuod, Omar Hezam, Ibrahim Aljaloud, Haitham Abdel Hamid Dawoud, Ahmed Abdusalam
  BioMed Research International.2020; 2020: 1.     CrossRef
• Diurnal influences of fasted and non-fasted brisk walking on gastric emptying rate, metabolic responses, and appetite in healthy males
  Victoria J. McIver, Lewis R. Mattin, Gethin H. Evans, Adora M.W. Yau
  Appetite.2019; 143: 104411.     CrossRef
• Myokine/Adipokine Response to “Aerobic” Exercise: Is It Just a Matter of Exercise Load?
  Zihong He, Ye Tian, Pedro L. Valenzuela, Chuanye Huang, Jiexiu Zhao, Ping Hong, Zilin He, Shuhui Yin, Alejandro Lucia
  Frontiers in Physiology.2019;[Epub]     CrossRef
• Exercise as ‘precision medicine’ for insulin resistance and its progression to type 2 diabetes: a research review
  Fred J. DiMenna, Avigdor D. Arad
  BMC Sports Science, Medicine and Rehabilitation.2018;[Epub]     CrossRef
• High-intensity aerobic interval training improves aerobic fitness and HbA1c among persons diagnosed with type 2 diabetes
  Eva Maria Støa, Sondre Meling, Lill-Katrin Nyhus, Glenn Strømstad, Karl Magnus Mangerud, Jan Helgerud, Solfrid Bratland-Sanda, Øyvind Støren
  European Journal of Applied Physiology.2017; 117(3): 455.     CrossRef

About this article

Suk MH, Moon YJ, Park SW, Park CY, Shin YA. Maximal Fat Oxidation Rate during Exercise in Korean Women with Type 2 Diabetes Mellitus. Diabetes Metab J. 2015;39(4):328-334.

Received: May 28, 2014; Accepted: Sep 26, 2014

DOI: https://doi.org/10.4093/dmj.2015.39.4.328.

Download citation ↓